Making the change through acute medical team education: Inpatient risk assessment of stable pulmonary embolism cases at high risk of deterioration

摘要

IntroductionThe safety of optimal management of acute sub-massive or massive pulmonary embolism (PE) with thrombolytic agents remains unclear.1 Thrombolytic agents reduce mortality and improve right ventricular function, but increase the risk of major haemorrhage and stroke.2–4 Our project reviews current management of acute PE with evidence of myocardial necrosis and right ventricular strain, improving awareness by educating the medical teams and how best to investigate and treat such cases.